Additionally, the movement of T-cells from blood vessels to the tumor site is hindered by the downregulation of extravasation mediators, including vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) (15–17). Here, VCAM1 is linked to neoplasm.